Diabetes
The International Diabetes Foundation predicts that almost 350 million people will have diabetes by 2025, compared with 30 million people worldwide in 1985. In the United States today, a total of 20.8 million people—about 7 percent of the population—have diabetes. The disease can lead to serious complications, and the risk for death among people with diabetes is about twice that of people of similar age without diabetes.
Essential to managing diabetes properly is good blood glucose control, but many patients fail to achieve or maintain it. Despite the availability of many diabetes therapies, there is substantial unmet need for well-tolerated new treatments that provide sustained blood glucose control. A long-time innovator in the development of diabetes therapies, Bristol-Myers Squibb is building its pioneering role with compounds in development to address the unmet needs of patients with diabetes.